Syngenta's €500m 12 year comes without NIP
Syngenta, the company created in 2000 through the merger of the spun-off agribusinesses of Swiss pharmaceutical company Novartis and the UK's AstraZeneca, has priced a €500m 12.5 year bond.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
